Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714718 | PMC |
| http://dx.doi.org/10.1182/bloodadvances.2021005736 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A rare KMT2A::CBL transcript in an acute monoblastic leukemia patient with an unfavorable outcome.
Mol Biol Rep
April 2024
Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Background: Lysine [K] methyltransferase 2A (KMT2A, previously known as MLL) gene rearrangements are common in acute leukemias of various lineages and are associated with features such as chemotherapy resistance and rapid relapse. KMT2A::CBL is a rare fusion of unknown pathogenesis generated by a unique interstitial deletion of chromosome 11 that has been reported across a wide age range in both acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) patients. The leukemogenic effect of the KMT2A::CBL rearrangement and its association with clinical prognosis have not been well clarified.
View Article and Find Full Text PDFKMT2A-CBL rearrangements in acute leukemias: clinical characteristics and genetic breakpoints.
Blood Adv
December 2021
Institute of Pharmaceutical Biology/Diagnostic Center of Acute Leukemia, Goethe University, Frankfurt/Main, Germany.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!